Can't seem to find that 40-f form but I have no doubt they filed it. And it does state they will let us know if accepted. And to be clear I have no reason to think it wouldn't be.
BARRIE, ONTARIO – November 5, 2019 (GLOBE NEWSWIRE) - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF)
(FSE: MLZ) (the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation and
purification, is pleased to announce it has filed an application to list its common shares on the NASDAQ Stock
Market (the "NASDAQ"). The Company will continue to maintain the listing of its common shares on the Toronto
Stock Exchange under the symbol "LABS".
“We are thrilled to be entering the next phase of growth at MediPharm Labs including cross-listing on the
NASDAQ, one of the world’s foremost exchanges for emerging markets and technology, such as the burgeoning
cannabis sector,” said Pat McCutcheon, Chief Executive Officer, MediPharm Labs. “Listing alongside our peers
on the NASDAQ will enhance our visibility and access to a larger base of institutional and retail shareholders in
the U.S. and globally.”
In advance of its anticipated listing on the NASDAQ, MediPharm Labs will file a Form 40-F Registration Statement
with the United States Securities and Exchange Commission (the “SEC”).
The listing of the Company's common shares on the NASDAQ remains subject to the approval of the NASDAQ and
the satisfaction of all applicable listing and regulatory requirements, including the SEC declaring the Form 40-F
Registration Statement effective. The Company will provide updates on its progress upon receiving final approval.
AI
Market Data 
Markets 
